Mar 31, 2026
Gene therapy is rapidly emerging as a transformative approach for retinitis pigmentosa treatment and other retinal degenerative disorders, with the eye providing an ideal environment for targeted interventions. Notably, the retina became the first tissue to receive a retinitis pigmentosa gene therapy FDA approval i...
Read More...
Mar 04, 2024
Gene therapy is becoming a promising solution for retinal degenerative illnesses, particularly because the retina offers an excellent avenue for studying and treating eye-related issues. Importantly, it is the first tissue in the United States to receive approval for gene therapy in cases of inherited disorders. ...
Read More...
The Next Wave of Radioligand Therapies: 5 Candidates to Watch
Mar 20, 2026
Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI
Mar 06, 2026
Newsletter/Whitepaper